NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 May 18, 2026 424B5
10-Q May 15, 2026 10-Q
D Feb 25, 2026
10-Q Feb 17, 2026 10-Q
424B3 Dec 30, 2025 424B3
EFFECT Dec 19, 2025
CORRESP Dec 18, 2025
DEL AM Dec 16, 2025 DEL AM
S-3 Dec 15, 2025 FORM S-3
8-K Nov 26, 2025 FORM 8-K
8-K Nov 14, 2025 FORM 8-K
10-Q Nov 14, 2025 10-Q
424B5 Nov 12, 2025 424B5
424B5 Nov 12, 2025 424B5
DEF 14A Oct 8, 2025 DEF 14A
8-K Oct 1, 2025 FORM 8-K
10-K Sep 29, 2025 10-K
10-Q May 15, 2025 10-Q
10-Q Feb 14, 2025 10-Q
4 Jan 28, 2025 PRIMARY DOCUMENT
8-K Dec 12, 2024 FORM 8-K
10-Q Nov 14, 2024 10-Q
DEF 14A Oct 15, 2024 DEF 14A
10-K Sep 27, 2024 10-K
8-K Aug 9, 2024 FORM 8-K
← Newer Page 2 of 23 · 556 filings Older →